I don't have a strong opinion on MRNA. They have a lot of irons in the fire, and have had some good news of late w later stage pipeline as they look to move beyond just a covid vaccine - e.g. RSV, melanoma
dewophile, thanks for that detailed analysis. I had heard about their Flu setback. I am not sure it is wise to package a Covid vaccine with any other. I mean, the right-wing demonization of Covid vaccines isn't going to dissipate anytime soon, and that could impact sales.
I might do what I usually do when I am unsure. Nibble a bit to get my interest up so I can follow a company.
Speaking of Flu vaccines, I just came across this. It is behind a paywall but the gist is that this mRNA based vaccine is being touted as a universal vaccine as it uses 20 different antigens (A & B).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.